Related references
Note: Only part of the references are listed.Diastolic dysfunction in asymptomatic hemodialysis patients in the light of the current echocardiographic guidelines
Jan Malik et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2019)
Tissue Doppler imaging predicts outcomes in hemodialysis patients with preserved left ventricular function
Wei-Ming Huang et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2019)
A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients
Fabian Hammer et al.
KIDNEY INTERNATIONAL (2019)
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Pieske et al.
EUROPEAN HEART JOURNAL (2019)
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial
David M. Charytan et al.
KIDNEY INTERNATIONAL (2019)
Association of left atrial volume index and all-cause mortality in patients referred for routine cardiovascular magnetic resonance: a multicenter study
Mohammad A. Khan et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2019)
Effect of Spironolactone on Exercise Tolerance and Arterial Function in Older Adults with Heart Failure with Preserved Ejection Fraction
Bharathi Upadhya et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)
Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis
Marlies Antlanger et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2017)
Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation
Simon de Denus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Influence of Chronic Renal Failure on Cardiac Structure
Peter A. McCullough et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction
Wojciech Kosmala et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Sherif F. Nagueh et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2016)
Left Atrial Dysfunction in End-Stage Renal Disease Patients Treated by Hemodialysis
Jan Malik et al.
NEPHRON (2016)
Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone
Amil M. Shah et al.
CIRCULATION (2015)
Diastolic Dysfunction Is an Independent Predictor of Cardiovascular Events in Incident Dialysis Patients with Preserved Systolic Function
Jae Hyun Han et al.
PLOS ONE (2015)
Cardiac Structure and Function and Prognosis in Heart Failure With Preserved Ejection Fraction Findings From the Echocardiographic Study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
Amil M. Shah et al.
CIRCULATION-HEART FAILURE (2014)
Effects of Spironolactone Treatment in Elderly Women With Heart Failure and Preserved Left Ventricular Ejection Fraction
Karla M. Kurrelmeyer et al.
JOURNAL OF CARDIAC FAILURE (2014)
Proposal for a Functional Classification System of Heart Failure in Patients With End-Stage Renal Disease Proceedings of the Acute Dialysis Quality Initiative (ADQI) XI Workgroup
Lakhmir S. Chawla et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Rationale and design of the Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Study (MiREnDa)
Fabian Hammer et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Spironolactone for Heart Failure with Preserved Ejection Fraction
Bertram Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction The Aldo-DHF Randomized Controlled Trial
Frank Edelmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction
Frank Edelmann et al.
EUROPEAN HEART JOURNAL (2012)
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
Barry A. Borlaug et al.
EUROPEAN HEART JOURNAL (2011)
A Randomized Study of the Beneficial Effects of Aldosterone Antagonism on LV Function, Structure, and Fibrosis Markers in Metabolic Syndrome
Wojciech Kosmala et al.
JACC-CARDIOVASCULAR IMAGING (2011)
N-terminal proBNP-Marker of Cardiac Dysfunction, Fluid Overload, or Malnutrition in Hemodialysis Patients?
John Booth et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Mitral peak Doppler E-wave to peak mitral annulus velocity ratio is an accurate estimate of left ventricular filling pressure and predicts mortality in end-stage renal disease
R Sharma et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2006)
Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
RM Lang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2005)
Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure
PM Mottram et al.
CIRCULATION (2004)
Mechanisms of disease - Aldosterone in congestive heart failure
KT Weber
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
